| Preparation and evaluation of colon-targeted prodrugs of the microbial metabolite 3-indolepropionic acid as an anticolitic agent H Lee, S Park, S Ju, S Kim, JW Yoo, IS Yoon, DS Min, Y Jung Molecular pharmaceutics 18 (4), 1730-1741, 2021 | 14 | 2021 |
| A colon-targeted prodrug, 4-phenylbutyric acid-glutamic acid conjugate, ameliorates 2, 4-dinitrobenzenesulfonic acid-induced colitis in rats S Kim, S Lee, H Lee, S Ju, S Park, D Kwon, JW Yoo, IS Yoon, DS Min, ... Pharmaceutics 12 (9), 843, 2020 | 13 | 2020 |
| Colon-Targeted delivery facilitates the therapeutic switching of sofalcone, a gastroprotective agent, to an anticolitic drug via Nrf2 activation W Kim, S Kim, S Ju, H Lee, S Jeong, JW Yoo, IS Yoon, Y Jung Molecular Pharmaceutics 16 (9), 4007-4016, 2019 | 11 | 2019 |
| 5-[(3-Carboxy-4-hydroxyphenyl) diazenyl] nicotinic acid, an azo-linked mesalazine-nicotinic acid conjugate, is a colon-targeted mutual prodrug against dextran sulfate sodium … S Jeong, S Ju, S Park, Y Jung Journal of Pharmaceutical Investigation 51, 317-325, 2021 | 9 | 2021 |
| 5-Aminosalicylic acid azo-coupled with a GPR109A agonist is a colon-targeted anticolitic codrug with a reduced risk of skin toxicity S Jeong, H Lee, S Kim, S Ju, W Kim, H Cho, HY Kim, G Heo, E Im, JW Yoo, ... Molecular Pharmaceutics 17 (1), 167-179, 2019 | 8 | 2019 |
| Conjugation of amisulpride, an anti-psychotic agent, with 5-aminosalicylic acid via an azo bond yields an orally active mutual prodrug against rat colitis W Kim, D Kim, S Jeong, S Ju, H Lee, S Kim, JW Yoo, IS Yoon, Y Jung Pharmaceutics 11 (11), 585, 2019 | 7 | 2019 |
| N‐Acetylserotonin is an oxidation‐responsive activator of Nrf2 ameliorating colitis in rats C Kang, S Jeong, J Kim, S Ju, E Im, G Heo, S Park, JW Yoo, J Lee, ... Journal of Pineal Research 74 (1), e12835, 2023 | 6 | 2023 |
| Dapsone Azo-Linked with Two Mesalazine Moieties Is a “Me-Better” Alternative to Sulfasalazine C Kang, J Kim, S Ju, S Park, JW Yoo, IS Yoon, MS Kim, Y Jung Pharmaceutics 14 (3), 684, 2022 | 4 | 2022 |
| A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug S Park, C Kang, J Kim, S Ju, JW Yoo, IS Yoon, MS Kim, J Lee, Y Jung Molecular Pharmaceutics 19 (11), 3784-3794, 2022 | 3 | 2022 |
| Eletrophilic chemistry of tranilast is involved in its anti-colitic activity via Nrf2-HO-1 pathway activation S Jeong, C Kang, S Park, S Ju, JW Yoo, IS Yoon, H Yun, Y Jung Pharmaceuticals 14 (11), 1092, 2021 | 3 | 2021 |
| Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic S Hong, S Ju, JW Yoo, NC Ha, Y Jung Biomaterials Science 9 (19), 6584-6596, 2021 | 3 | 2021 |
| Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: Implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia C Kang, S Ju, J Kim, Y Jung Pharmacological Reports 75 (1), 211-221, 2023 | 2 | 2023 |
| Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A C Kang, J Kim, S Ju, H Cho, HY Kim, IS Yoon, JW Yoo, Y Jung Pharmaceutics 15 (1), 41, 2022 | 2 | 2022 |
| N-benzyl-N-methyldecan-1-amine and its derivative mitigate 2, 4-dinitrobenzenesulfonic acid-induced colitis and collagen-induced rheumatoid arthritis JE Kim, C Kang, P Budluang, N Yawut, IR Cho, YJ Choi, J Kim, S Ju, ... Frontiers in Pharmacology 14, 1095955, 2023 | 1 | 2023 |
